NICE has issued guidance to the NHS in England and Wales on the use of long-acting insulin analogues for diabetes. In summary:
Insulin glargine is recommended as a treatment option for people with type 1 diabetes. Insulin glargine is not recommended for routine use for people with type 2 diabetes who require insulin therapy.
Insulin glargine treatment should be considered only for those people with type 2 diabetes who require insulin therapy and who fall into one of the following categories: – Those who require assistance from a carer or healthcare professional to administer their insulin injections. – Those whose lifestyle is significantly restricted by recurrent symptomatic hypoglycaemic episodes. – Those who would otherwise need twice-daily basal insulin injections in combination with oral antidiabetic drugs.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!